Edwards Lifesciences Corp EW
i
Market dataready · fetched 2026-11-04T00:30:27.189Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-04T00:00:00.002320075Z
FundamentalsSEC EDGAR · ready · as of 2026-06-30 · fetched 2026-11-04T00:30:26.639432+00:00
Edwards Lifesciences Corp options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 103.09 | 39.3% | 9.2% | 88.51 | 42.9% | 8.1% |
| 25Δ | 101.62 | 39.5% | 8.0% | 90.03 | 42.4% | 6.8% |
| 30Δ | 100.15 | 39.8% | 6.8% | 91.19 | 43.1% | 6.1% |
| 35Δ | 99.09 | 41.6% | 6.2% | 92.36 | 43.9% | 5.3% |
| 40Δ | 98.07 | 43.5% | 5.6% | 93.51 | 41.4% | 4.4% |
| 45Δ | 96.98 | 44.6% | 5.0% | 94.65 | 38.5% | 3.5% |
| 50Δ | 95.82 | 44.8% | 4.3% | 95.81 | 39.9% | 3.1% |
| 55Δ | 94.66 | 44.6% | 3.7% | 96.98 | 43.1% | 2.8% |
| 60Δ | 93.53 | 43.9% | 3.1% | 98.15 | 44.2% | 2.4% |
| 65Δ | 92.39 | 43.2% | 2.5% | 99.33 | 43.6% | 1.9% |
| 70Δ | 91.17 | 43.1% | 2.1% | 100.63 | 43.0% | 1.5% |
| 75Δ | 89.95 | 43.1% | 1.6% | 102.08 | 42.4% | 1.2% |
| 80Δ | 88.60 | 42.4% | 1.3% | 103.54 | 41.8% | 0.8% |
20Δ
- Pseudo strike
- 103.09
- IV
- 39.3%
- B/E move
- 9.2%
- Pseudo strike
- 88.51
- IV
- 42.9%
- B/E move
- 8.1%
25Δ
- Pseudo strike
- 101.62
- IV
- 39.5%
- B/E move
- 8.0%
- Pseudo strike
- 90.03
- IV
- 42.4%
- B/E move
- 6.8%
30Δ
- Pseudo strike
- 100.15
- IV
- 39.8%
- B/E move
- 6.8%
- Pseudo strike
- 91.19
- IV
- 43.1%
- B/E move
- 6.1%
35Δ
- Pseudo strike
- 99.09
- IV
- 41.6%
- B/E move
- 6.2%
- Pseudo strike
- 92.36
- IV
- 43.9%
- B/E move
- 5.3%
40Δ
- Pseudo strike
- 98.07
- IV
- 43.5%
- B/E move
- 5.6%
- Pseudo strike
- 93.51
- IV
- 41.4%
- B/E move
- 4.4%
45Δ
- Pseudo strike
- 96.98
- IV
- 44.6%
- B/E move
- 5.0%
- Pseudo strike
- 94.65
- IV
- 38.5%
- B/E move
- 3.5%
50Δ
- Pseudo strike
- 95.82
- IV
- 44.8%
- B/E move
- 4.3%
- Pseudo strike
- 95.81
- IV
- 39.9%
- B/E move
- 3.1%
55Δ
- Pseudo strike
- 94.66
- IV
- 44.6%
- B/E move
- 3.7%
- Pseudo strike
- 96.98
- IV
- 43.1%
- B/E move
- 2.8%
60Δ
- Pseudo strike
- 93.53
- IV
- 43.9%
- B/E move
- 3.1%
- Pseudo strike
- 98.15
- IV
- 44.2%
- B/E move
- 2.4%
65Δ
- Pseudo strike
- 92.39
- IV
- 43.2%
- B/E move
- 2.5%
- Pseudo strike
- 99.33
- IV
- 43.6%
- B/E move
- 1.9%
70Δ
- Pseudo strike
- 91.17
- IV
- 43.1%
- B/E move
- 2.1%
- Pseudo strike
- 100.63
- IV
- 43.0%
- B/E move
- 1.5%
75Δ
- Pseudo strike
- 89.95
- IV
- 43.1%
- B/E move
- 1.6%
- Pseudo strike
- 102.08
- IV
- 42.4%
- B/E move
- 1.2%
80Δ
- Pseudo strike
- 88.60
- IV
- 42.4%
- B/E move
- 1.3%
- Pseudo strike
- 103.54
- IV
- 41.8%
- B/E move
- 0.8%
Options history
Table
| Date | IV (%) |
|---|---|
| 28.41% | |
| 30.15% | |
| 27.87% | |
| 29.16% | |
| 27.96% | |
| 27.09% | |
| 27.95% | |
| 28.13% | |
| 31.26% | |
| 27.13% | |
| 29.23% | |
| 31.32% | |
| 27.75% | |
| 28.54% | |
| 28.08% | |
| 26.73% | |
| 26.61% | |
| 26.81% | |
| 27.27% | |
| 26.83% | |
| 26.74% | |
| 26.06% | |
| 25.92% | |
| 28.61% | |
| 27.73% | |
| 28.52% | |
| 29.37% | |
| 28.87% | |
| 30.72% | |
| 35.27% | |
| 33.71% | |
| 28.85% | |
| 31.13% | |
| 30.12% | |
| 30.36% | |
| 32.54% | |
| 31.39% | |
| 30.71% | |
| 31.17% | |
| 31.20% | |
| 31.89% | |
| 30.67% | |
| 30.24% | |
| 31.61% | |
| 32.08% | |
| 31.32% | |
| 32.21% | |
| 33.89% | |
| 33.55% | |
| 35.35% | |
| 40.13% | |
| 35.16% | |
| 35.03% | |
| 36.01% | |
| 36.18% | |
| 37.09% | |
| 35.74% | |
| 36.78% | |
| 36.88% | |
| 35.50% | |
| 41.80% | |
| 40.14% |
Medical Devices
GEHC
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago,…
More →GKOS
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, is focused on developing new therapies for the treatment of glaucoma, corneal disorders, and…
More →GMED
Globus Medical, Inc., a medical device company, develops and markets healthcare solutions for patients with musculoskeletal disorders. The company is headquartered in Audubon,…
More →HAE
Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.
More →HYPR
Hyperfine Inc. is a pioneering force in medical technology, renowned for developing the world’s first FDA-cleared portable MRI system, which significantly enhances diagnostic…
More →IART
Description unavailable
More →